Astrocytoma Idh Mutant Grade 2 C4289692
A typically slow-growing brain tumor arising from astrocytes. It commonly affects adults in their 30s and 40s. Treatment may involve surgery, radiation, and monitoring, depending on tumor characteristics and location.
Key facts at a glance
- ICD-10
- C80.1
- ICD-11
- 2A00.0
- Body system
- oncologic
- Severity
- moderate
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Warning signs - seek immediate care
Seizures
Focal neurological deficit
Generalized symptoms
(oncologic)Noticeable symptoms that may vary in intensity over time.
Frequency: Common at all stages
Headache
(oncologic)Visual disturbances
(oncologic)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Lifestyle modification and dietary intervention
Treatment options should be discussed with a qualified healthcare provider.
Maximal Safe Surgical Resection
Neurosurgical tumor removal with the goal of maximal safe resection while preserving neurological function, as extent of resection correlates with progression-free survival.
Chemotherapy with PCV or Temozolomide
Chemotherapy regimens, either PCV (procarbazine, lomustine, vincristine) or temozolomide, may be used as adjunctive treatment following surgery or for unresectable tumors.
Additional treatment options
Focal Radiation Therapy
Precision radiation therapy targeting the tumor bed and residual disease, typically delivered over several weeks with careful sparing of surrounding healthy brain tissue.
procedureAntiepileptic Drug Therapy
Seizure control through appropriate antiepileptic medications, selected based on drug interactions, side effect profiles, and patient-specific factors including age and comorbidities.
medicationSerial MRI Surveillance
Regular magnetic resonance imaging scans with contrast to monitor for tumor progression, pseudoprogression, or recurrence, typically every 3-6 months initially.
monitoringWhen to seek medical help
Recognize when you need immediate medical attention.
Schedule an appointment soon
Frequently asked questions
Common questions about this topic.
What is Astrocytoma Idh Mutant Grade 2 C4289692?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Louis DN, Wesseling P, Paulus W, et al. cIMPACT-NOW update 7: incorporating integrated molecular diagnosis into the WHO classification of adult diffuse gliomas. Neuropathol Appl Neurobiol. 2022.
Eckel-Passow JE, Lachance DH, Molinaro AM, et al. Defining the prognosis of IDH-mutant astrocytomas based on histologic grade and patient age. J Neurooncol. 2020.
van den Bent MJ, Baumert B, Erridge SC, et al. Long-term outcome of the European Organisation for Research and Treatment of Cancer trial in patients with low-grade glioma. J Clin Oncol. 2019.
Reuss DE, Sahm F, Schrimpf D, et al. IDH mutant diffuse astrocytomas: molecular characteristics and clinical implications. Acta Neuropathol. 2021.
Medication Comparisons
Compare medications used to treat Astrocytoma Idh Mutant Grade 2 C4289692. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy